Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 62 entries
Sorted by: Best Match Show Resources per page
Time for Practical Clinical Tools.

Arrhythmia & electrophysiology review

Katritsis D.
PMID: 29018512
Arrhythm Electrophysiol Rev. 2017 Aug;6(3):103. doi: 10.15420/AER.2017.6.3.FO1.

No abstract available.

Cite
Katritsis D. Time for Practical Clinical Tools. Arrhythm Electrophysiol Rev. 2017;6(3):103doi: 10.15420/AER.2017.6.3.FO1.
Katritsis, D. (2017). Time for Practical Clinical Tools. Arrhythmia & electrophysiology review, 6(3), 103. https://doi.org/10.15420/AER.2017.6.3.FO1
Katritsis, Demosthenes. "Time for Practical Clinical Tools." Arrhythmia & electrophysiology review vol. 6,3 (2017): 103. doi: https://doi.org/10.15420/AER.2017.6.3.FO1
Katritsis D. Time for Practical Clinical Tools. Arrhythm Electrophysiol Rev. 2017 Aug;6(3):103. doi: 10.15420/AER.2017.6.3.FO1. PMID: 29018512; PMCID: PMC5610736.
Copy Download .nbib Format: NLM
Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention.

Arrhythmia & electrophysiology review

Silverstein JR, Katritsis DG, Josephson ME.
PMID: 26835029
Arrhythm Electrophysiol Rev. 2012 Sep;1(1):46-50. doi: 10.15420/aer.2012.1.46.

Sudden cardiac death (SCD) is one of the leading causes of mortality in developed countries. Internal cardioverter defibrillators (ICDs) have been developed to treat potentially life-threatening ventricular arrhythmias. Multiple randomised trials have been completed to assess the efficacy of...

Cite
Silverstein JR, Katritsis DG, Josephson ME. Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention. Arrhythm Electrophysiol Rev. 2012;1(1):46-50doi: 10.15420/aer.2012.1.46.
Silverstein, J. R., Katritsis, D. G., & Josephson, M. E. (2012). Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention. Arrhythmia & electrophysiology review, 1(1), 46-50. https://doi.org/10.15420/aer.2012.1.46
Silverstein, Joshua R, et al. "Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention." Arrhythmia & electrophysiology review vol. 1,1 (2012): 46-50. doi: https://doi.org/10.15420/aer.2012.1.46
Silverstein JR, Katritsis DG, Josephson ME. Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention. Arrhythm Electrophysiol Rev. 2012 Sep;1(1):46-50. doi: 10.15420/aer.2012.1.46. PMID: 26835029; PMCID: PMC4711493.
Copy Download .nbib Format: NLM
Arrhythmia & Electrophysiology Review - A Promising Start.

Arrhythmia & electrophysiology review

Katritsis D.
PMID: 26835033
Arrhythm Electrophysiol Rev. 2013 Apr;2(1):6. doi: 10.15420/aer.2013.2.1.6.

No abstract available.

Cite
Katritsis D. Arrhythmia & Electrophysiology Review - A Promising Start. Arrhythm Electrophysiol Rev. 2013;2(1):6doi: 10.15420/aer.2013.2.1.6.
Katritsis, D. (2013). Arrhythmia & Electrophysiology Review - A Promising Start. Arrhythmia & electrophysiology review, 2(1), 6. https://doi.org/10.15420/aer.2013.2.1.6
Katritsis, Demosthenes. "Arrhythmia & Electrophysiology Review - A Promising Start." Arrhythmia & electrophysiology review vol. 2,1 (2013): 6. doi: https://doi.org/10.15420/aer.2013.2.1.6
Katritsis D. Arrhythmia & Electrophysiology Review - A Promising Start. Arrhythm Electrophysiol Rev. 2013 Apr;2(1):6. doi: 10.15420/aer.2013.2.1.6. PMID: 26835033; PMCID: PMC4711524.
Copy Download .nbib Format: NLM
Arrhythmia & Electrophysiology Review - Time to Reflect.

Arrhythmia & electrophysiology review

Katritsis D.
PMID: 26835080
Arrhythm Electrophysiol Rev. 2014 Nov;3(3):138. doi: 10.15420/aer.2014.3.3.138. Epub 2014 Nov 29.

No abstract available.

Cite
Katritsis D. Arrhythmia & Electrophysiology Review - Time to Reflect. Arrhythm Electrophysiol Rev. 2014;3(3):138doi: 10.15420/aer.2014.3.3.138.
Katritsis, D. (2014). Arrhythmia & Electrophysiology Review - Time to Reflect. Arrhythmia & electrophysiology review, 3(3), 138. https://doi.org/10.15420/aer.2014.3.3.138
Katritsis, Demosthenes. "Arrhythmia & Electrophysiology Review - Time to Reflect." Arrhythmia & electrophysiology review vol. 3,3 (2014): 138. doi: https://doi.org/10.15420/aer.2014.3.3.138
Katritsis D. Arrhythmia & Electrophysiology Review - Time to Reflect. Arrhythm Electrophysiol Rev. 2014 Nov;3(3):138. doi: 10.15420/aer.2014.3.3.138. Epub 2014 Nov 29. PMID: 26835080; PMCID: PMC4712619.
Copy Download .nbib Format: NLM
Early Repolarisation Syndrome - New Concepts.

Arrhythmia & electrophysiology review

Katritsis DG, Gersh BJ, Camm AJ.
PMID: 26835120
Arrhythm Electrophysiol Rev. 2015 Dec;4(3):169-71. doi: 10.15420/aer.2015.4.3.169. Epub 2015 Dec 01.

New concepts regarding early repolarisation syndrome are presented. Genetics and epidemiology data, as well as new evidence on the potential clinical significance of early repolarisation patterns, are discussed.

Cite
Katritsis DG, Gersh BJ, Camm AJ. Early Repolarisation Syndrome - New Concepts. Arrhythm Electrophysiol Rev. 2015;4(3):169-71doi: 10.15420/aer.2015.4.3.169.
Katritsis, D. G., Gersh, B. J., & Camm, A. J. (2015). Early Repolarisation Syndrome - New Concepts. Arrhythmia & electrophysiology review, 4(3), 169-71. https://doi.org/10.15420/aer.2015.4.3.169
Katritsis, Demosthenes G, et al. "Early Repolarisation Syndrome - New Concepts." Arrhythmia & electrophysiology review vol. 4,3 (2015): 169-71. doi: https://doi.org/10.15420/aer.2015.4.3.169
Katritsis DG, Gersh BJ, Camm AJ. Early Repolarisation Syndrome - New Concepts. Arrhythm Electrophysiol Rev. 2015 Dec;4(3):169-71. doi: 10.15420/aer.2015.4.3.169. Epub 2015 Dec 01. PMID: 26835120; PMCID: PMC4732029.
Copy Download .nbib Format: NLM
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality.

JACC. Clinical electrophysiology

Siontis KC, Ioannidis JPA, Katritsis GD, Noseworthy PA, Packer DL, Hummel JD, Jais P, Krittayaphong R, Mont L, Morillo CA, Nielsen JC, Oral H, Pappone C, Santinelli V, Weerasooriya R, Wilber DJ, Gersh BJ, Josephson ME, Katritsis DG.
PMID: 29766867
JACC Clin Electrophysiol. 2016 Apr;2(2):170-180. doi: 10.1016/j.jacep.2015.10.003. Epub 2015 Nov 10.

OBJECTIVES: The aim of this study was to perform a collaborative meta-analysis of published and unpublished quality-of-life, morbidity, and mortality data from randomized controlled trial comparisons of radiofrequency ablation (RFA) and antiarrhythmic drug therapy (AAD) in symptomatic atrial fibrillation.BACKGROUND:...

Cite
Siontis KC, Ioannidis JPA, Katritsis GD, et al. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. JACC Clin Electrophysiol. 2015;2(2):170-180doi: 10.1016/j.jacep.2015.10.003.
Siontis, K. C., Ioannidis, J. P. A., Katritsis, G. D., Noseworthy, P. A., Packer, D. L., Hummel, J. D., Jais, P., Krittayaphong, R., Mont, L., Morillo, C. A., Nielsen, J. C., Oral, H., Pappone, C., Santinelli, V., Weerasooriya, R., Wilber, D. J., Gersh, B. J., Josephson, M. E., & Katritsis, D. G. (2016). Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. JACC. Clinical electrophysiology, 2(2), 170-180. https://doi.org/10.1016/j.jacep.2015.10.003
Siontis, Konstantinos C, et al. "Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality." JACC. Clinical electrophysiology vol. 2,2 (2016): 170-180. doi: https://doi.org/10.1016/j.jacep.2015.10.003
Siontis KC, Ioannidis JPA, Katritsis GD, Noseworthy PA, Packer DL, Hummel JD, Jais P, Krittayaphong R, Mont L, Morillo CA, Nielsen JC, Oral H, Pappone C, Santinelli V, Weerasooriya R, Wilber DJ, Gersh BJ, Josephson ME, Katritsis DG. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. JACC Clin Electrophysiol. 2016 Apr;2(2):170-180. doi: 10.1016/j.jacep.2015.10.003. Epub 2015 Nov 10. PMID: 29766867.
Copy Download .nbib Format: NLM
Management of Complications in Anticoagulated Patients with Atrial Fibrillation.

Arrhythmia & electrophysiology review

Katritsis GD, Katritsis DG.
PMID: 29326831
Arrhythm Electrophysiol Rev. 2017 Dec;6(4):167-178. doi: 10.15420/aer.2017.23.1.

Oral anticoagulation is mandatory for patients at high risk of thromboembolism, but the risk of bleeding should also be taken into account. Direct oral anticoagulants are now recommended for non-valvular AF as a potential alternative to warfarin. In this...

Cite
Katritsis GD, Katritsis DG. Management of Complications in Anticoagulated Patients with Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2017;6(4):167-178doi: 10.15420/aer.2017.23.1.
Katritsis, G. D., & Katritsis, D. G. (2017). Management of Complications in Anticoagulated Patients with Atrial Fibrillation. Arrhythmia & electrophysiology review, 6(4), 167-178. https://doi.org/10.15420/aer.2017.23.1
Katritsis, George D, and Katritsis, Demosthenes G. "Management of Complications in Anticoagulated Patients with Atrial Fibrillation." Arrhythmia & electrophysiology review vol. 6,4 (2017): 167-178. doi: https://doi.org/10.15420/aer.2017.23.1
Katritsis GD, Katritsis DG. Management of Complications in Anticoagulated Patients with Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2017 Dec;6(4):167-178. doi: 10.15420/aer.2017.23.1. PMID: 29326831; PMCID: PMC5739886.
Copy Download .nbib Format: NLM
Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?.

Arrhythmia & electrophysiology review

Katritsis DG, Auricchio A.
PMID: 30416727
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):157-158. doi: 10.15420/aer.2018.7.3.EO1.

No abstract available.

Cite
Katritsis DG, Auricchio A. Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?. Arrhythm Electrophysiol Rev. 2018;7(3):157-158doi: 10.15420/aer.2018.7.3.EO1.
Katritsis, D. G., & Auricchio, A. (2018). Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?. Arrhythmia & electrophysiology review, 7(3), 157-158. https://doi.org/10.15420/aer.2018.7.3.EO1
Katritsis, Demosthenes G, and Auricchio, Angelo. "Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?." Arrhythmia & electrophysiology review vol. 7,3 (2018): 157-158. doi: https://doi.org/10.15420/aer.2018.7.3.EO1
Katritsis DG, Auricchio A. Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?. Arrhythm Electrophysiol Rev. 2018 Aug;7(3):157-158. doi: 10.15420/aer.2018.7.3.EO1. PMID: 30416727; PMCID: PMC6141914.
Copy Download .nbib Format: NLM
"What Cannot be Missed": a New Service of Arrhythmia and Electrophysiology Review.

Arrhythmia & electrophysiology review

Katritsis DG.
PMID: 29636965
Arrhythm Electrophysiol Rev. 2018 Mar;7(1):6. doi: 10.15420/aer.2018.7.1.FO1.

No abstract available.

Cite
Katritsis DG. "What Cannot be Missed": a New Service of Arrhythmia and Electrophysiology Review. Arrhythm Electrophysiol Rev. 2018;7(1):6doi: 10.15420/aer.2018.7.1.FO1.
Katritsis, D. G. (2018). "What Cannot be Missed": a New Service of Arrhythmia and Electrophysiology Review. Arrhythmia & electrophysiology review, 7(1), 6. https://doi.org/10.15420/aer.2018.7.1.FO1
Katritsis, Demosthenes G. ""What Cannot be Missed": a New Service of Arrhythmia and Electrophysiology Review." Arrhythmia & electrophysiology review vol. 7,1 (2018): 6. doi: https://doi.org/10.15420/aer.2018.7.1.FO1
Katritsis DG. "What Cannot be Missed": a New Service of Arrhythmia and Electrophysiology Review. Arrhythm Electrophysiol Rev. 2018 Mar;7(1):6. doi: 10.15420/aer.2018.7.1.FO1. PMID: 29636965; PMCID: PMC5889809.
Copy Download .nbib Format: NLM
What Cannot be Missed: Must-read Papers, 2018.

Arrhythmia & electrophysiology review

Katritsis DG.
PMID: 31114680
Arrhythm Electrophysiol Rev. 2019 May;8(2):81-82. doi: 10.15420/aer.2019.8.2.FO1.

No abstract available.

Cite
Katritsis DG. What Cannot be Missed: Must-read Papers, 2018. Arrhythm Electrophysiol Rev. 2019;8(2):81-82doi: 10.15420/aer.2019.8.2.FO1.
Katritsis, D. G. (2019). What Cannot be Missed: Must-read Papers, 2018. Arrhythmia & electrophysiology review, 8(2), 81-82. https://doi.org/10.15420/aer.2019.8.2.FO1
Katritsis, Demosthenes G. "What Cannot be Missed: Must-read Papers, 2018." Arrhythmia & electrophysiology review vol. 8,2 (2019): 81-82. doi: https://doi.org/10.15420/aer.2019.8.2.FO1
Katritsis DG. What Cannot be Missed: Must-read Papers, 2018. Arrhythm Electrophysiol Rev. 2019 May;8(2):81-82. doi: 10.15420/aer.2019.8.2.FO1. PMID: 31114680; PMCID: PMC6528029.
Copy Download .nbib Format: NLM
Evolution of the Editorial Board Underpins the Integrity of .

Arrhythmia & electrophysiology review

Katritsis DG.
PMID: 29967676
Arrhythm Electrophysiol Rev. 2018 Jun;7(2):74. doi: 10.15420/aer.2018.7.2.FO1.

No abstract available.

Cite
Katritsis DG. Evolution of the Editorial Board Underpins the Integrity of . Arrhythm Electrophysiol Rev. 2018;7(2):74doi: 10.15420/aer.2018.7.2.FO1.
Katritsis, D. G. (2018). Evolution of the Editorial Board Underpins the Integrity of . Arrhythmia & electrophysiology review, 7(2), 74. https://doi.org/10.15420/aer.2018.7.2.FO1
Katritsis, Demosthenes G. "Evolution of the Editorial Board Underpins the Integrity of ." Arrhythmia & electrophysiology review vol. 7,2 (2018): 74. doi: https://doi.org/10.15420/aer.2018.7.2.FO1
Katritsis DG. Evolution of the Editorial Board Underpins the Integrity of . Arrhythm Electrophysiol Rev. 2018 Jun;7(2):74. doi: 10.15420/aer.2018.7.2.FO1. PMID: 29967676; PMCID: PMC6020189.
Copy Download .nbib Format: NLM
The Specialized Atrioventricular Ring Tissues Participate in the Circuit of Atrioventricular Nodal Reentrant Tachycardia.

Journal of the American Heart Association

Katritsis DG, Calkins H, Anderson RH.
PMID: 34719243
J Am Heart Assoc. 2021 Nov 16;10(22):e022811. doi: 10.1161/JAHA.121.022811. Epub 2021 Oct 30.

No abstract available.

Cite
Katritsis DG, Calkins H, Anderson RH. The Specialized Atrioventricular Ring Tissues Participate in the Circuit of Atrioventricular Nodal Reentrant Tachycardia. J Am Heart Assoc. 2021;10(22):e022811doi: 10.1161/JAHA.121.022811.
Katritsis, D. G., Calkins, H., & Anderson, R. H. (2021). The Specialized Atrioventricular Ring Tissues Participate in the Circuit of Atrioventricular Nodal Reentrant Tachycardia. Journal of the American Heart Association, 10(22), e022811. https://doi.org/10.1161/JAHA.121.022811
Katritsis, Demosthenes G, et al. "The Specialized Atrioventricular Ring Tissues Participate in the Circuit of Atrioventricular Nodal Reentrant Tachycardia." Journal of the American Heart Association vol. 10,22 (2021): e022811. doi: https://doi.org/10.1161/JAHA.121.022811
Katritsis DG, Calkins H, Anderson RH. The Specialized Atrioventricular Ring Tissues Participate in the Circuit of Atrioventricular Nodal Reentrant Tachycardia. J Am Heart Assoc. 2021 Nov 16;10(22):e022811. doi: 10.1161/JAHA.121.022811. Epub 2021 Oct 30. PMID: 34719243.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 62 entries